Literature DB >> 12784257

Cell-free DNA is released from tumor cells upon cell death: a study of tissue cultures of tumor cell lines.

Chia-Ni Li1, Hui-Lun Hsu, Tsu-Lan Wu, Kuo-Chien Tsao, Chien-Feng Sun, James T Wu.   

Abstract

To determine the source of cell-free DNA detected in the serum of cancer patients, we monitored the release of cell-free DNA and tumor markers from tumor cell lines using the cell culture technique. During the first 6 days of cell culture, we found very low concentrations of DNA and a steady increase of the CA 125 released from the SK-BR3 tumor cell lines during cell growth. A sudden increase of cell-free DNA detected in the cell medium coincided with cell death. As the cells died, the concentration of cell-free DNA declined but the concentration of CA 125 increased. The sudden release of cell-free DNA observed upon cell death was also found on the cell cultures of additional tumor cell lines, including A549, RD, and SK-N-SH cells. It appears that the majority of cell-free DNA detected in the serum of cancer patients comes from tumor cells following cell death and cell necrosis. The concentration of cell-free DNA released is related to the number of dead cells, whereas that of the tumor marker CA 125 is associated with the presence of the total number of cells (dead or alive). Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784257      PMCID: PMC6807943          DOI: 10.1002/jcla.10081

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

Authors:  S Jahr; H Hentze; S Englisch; D Hardt; F O Fackelmayer; R D Hesch; R Knippers
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 2.  Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients.

Authors:  P Anker; H Mulcahy; X Q Chen; M Stroun
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

3.  Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer.

Authors:  J Sjöström; H Alfthan; H Joensuu; U H Stenman; J Lundin; C Blomqvist
Journal:  Scand J Clin Lab Invest       Date:  2001       Impact factor: 1.713

4.  Cell-free DNA: measurement in various carcinomas and establishment of normal reference range.

Authors:  Tsu-Lan Wu; Diana Zhang; Ju-Hsin Chia; Kuo -hien Tsao; Chien-Feng Sun; James T Wu
Journal:  Clin Chim Acta       Date:  2002-07       Impact factor: 3.786

5.  Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker.

Authors:  Chien-Feng Sun; Thomas R Haven; Tsu-Lan Wu; Kuo-Chien Tsao; James T Wu
Journal:  Clin Chim Acta       Date:  2002-07       Impact factor: 3.786

6.  Plasma DNA as cell death marker in elderly patients.

Authors:  G J Fournié; F Martres; J P Pourrat; C Alary; M Rumeau
Journal:  Gerontology       Date:  1993       Impact factor: 5.140

Review 7.  C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment.

Authors:  James T Wu
Journal:  Clin Chim Acta       Date:  2002-08       Impact factor: 3.786

8.  Isolation and characterization of DNA from the plasma of cancer patients.

Authors:  M Stroun; P Anker; J Lyautey; C Lederrey; P A Maurice
Journal:  Eur J Cancer Clin Oncol       Date:  1987-06

9.  Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.

Authors:  G J Fournié; J P Courtin; F Laval; J J Chalé; J P Pourrat; M C Pujazon; D Lauque; P Carles
Journal:  Cancer Lett       Date:  1995-05-08       Impact factor: 8.679

10.  Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease.

Authors:  B Shapiro; M Chakrabarty; E M Cohn; S A Leon
Journal:  Cancer       Date:  1983-06-01       Impact factor: 6.860

  10 in total
  13 in total

Review 1.  Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.

Authors:  Paola Ulivi; Rosella Silvestrini
Journal:  Cell Oncol (Dordr)       Date:  2013-11-01       Impact factor: 6.730

Review 2.  Liquid biopsy: monitoring cancer-genetics in the blood.

Authors:  Emily Crowley; Federica Di Nicolantonio; Fotios Loupakis; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2013-07-09       Impact factor: 66.675

Review 3.  Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Authors:  André Nogueira da Costa; Zdenko Herceg
Journal:  Mol Oncol       Date:  2012-08-16       Impact factor: 6.603

4.  Circulating Exosomal-DNA in Glioma Patients: A Quantitative Study and Histopathological Correlations-A Preliminary Study.

Authors:  Amedeo Piazza; Paolo Rosa; Luca Ricciardi; Antonella Mangraviti; Luca Pacini; Antonella Calogero; Antonino Raco; Massimo Miscusi
Journal:  Brain Sci       Date:  2022-04-14

5.  Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients.

Authors:  Andrew Rhodes; Stephen J Wort; Helen Thomas; Paul Collinson; E David Bennett
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.

Authors:  A Szpechcinski; J Chorostowska-Wynimko; R Struniawski; W Kupis; P Rudzinski; R Langfort; E Puscinska; P Bielen; P Sliwinski; T Orlowski
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

7.  Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer.

Authors:  E Danese; A M Minicozzi; M Benati; M Montagnana; E Paviati; G L Salvagno; M Gusella; F Pasini; G C Guidi; G Lippi
Journal:  Br J Cancer       Date:  2013-07-09       Impact factor: 7.640

8.  The plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome.

Authors:  Xiaoling Gu; Yanwen Yao; Guannan Wu; Tangfeng Lv; Liang Luo; Yong Song
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

9.  Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.

Authors:  José A González-Masiá; Damián García-Olmo; Dolores C García-Olmo
Journal:  Onco Targets Ther       Date:  2013-07-08       Impact factor: 4.147

10.  Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.

Authors:  Yusuke Hiraku; Feiye Guo; Ning Ma; Tatsuhiko Yamada; Shumin Wang; Shosuke Kawanishi; Mariko Murata
Journal:  Part Fibre Toxicol       Date:  2016-03-29       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.